4//SEC Filing
Chang David J. 4
Accession 0000950170-25-032295
CIK 0001759138other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:48 PM ET
Size
5.4 KB
Accession
0000950170-25-032295
Insider Transaction Report
Form 4
Chang David J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+145,000→ 145,000 totalExercise: $1.67Exp: 2035-03-02→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on March 3, 2026, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.
Documents
Issuer
Cabaletta Bio, Inc.
CIK 0001759138
Entity typeother
Related Parties
1- filerCIK 0001790552
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:48 PM ET
- Size
- 5.4 KB